Europe Mumps Virus Testing Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Europe Mumps Virus Testing Market Analysis — Presence
Geographical Analysis
Click countries to exploreCountry Analysis
Europe Mumps Virus Testing Market Analysis 2026
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Europe Mumps Virus Testing Total | xxxx | xxxx | xxxx | 10.5% |
| United Kingdom | xxxx | xxxx | xxxx | 11.3% |
| France | xxxx | xxxx | xxxx | 9.7% |
| Germany | xxxx | xxxx | xxxx | 10.7% |
| Italy | xxxx | xxxx | xxxx | 9.9% |
| Russia | xxxx | xxxx | xxxx | 9.5% |
| Spain | xxxx | xxxx | xxxx | 9.6% |
| Sweden | xxxx | xxxx | xxxx | xxxx |
| Denmark | xxxx | xxxx | xxxx | xxxx |
| Switzerland | xxxx | xxxx | xxxx | xxxx |
| Luxembourg | xxxx | xxxx | xxxx | xxxx |
| Rest of Europe | xxxx | xxxx | xxxx | 9.2% |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Segmentation Analysis
Testing type breakdown · Illustrative 2025 shares shown free · Full-period forecast in paid report.
Disclaimer: The charts and graphs are for illustrative purposes only and do not represent actual market values. To access accurate quantitative data, please request a paid report or request free sample.
To learn more about market share and segmentation, request the free sample pages.
Competitor Analysis
Competitive Landscape of the Mumps Virus Testing Market
The competitive landscape of the Mumps Virus Testing Market is marked by the dominance of major diagnostic companies, the rise of innovative smaller players, and the continuous push for technological advancements and strategic collaborations to address the growing demand for reliable and accessible mumps testing solutions.
November 2023: Amkor Technology, Inc. said that it will establish goals to lower greenhouse gas emissions in accordance with the Science Based Targets program (SBTi). (Source: https://ir.amkor.com/news-releases/news-release-details/amkor-technology-signs-commitment-science-based-targets) June 2022: The United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA) granted marketing authorization for the VBI Vaccines' PreHevbri (Hepatitis B vaccine (recombinant, adsorbed)) for active immunization against infection caused by all known subtypes of the hepatitis B virus (HBV) in adults. (Source: https://www.vbivaccines.com/press-releases/uk-mhra-marketing-authorisation-for-prehevbri/)
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Company 1 | ••• | ••• | ••• | ••• |
| Company 2 | ••• | ••• | ••• | ••• |
| Company 3 | ••• | ••• | ••• | ••• |
| Company 4 | ••• | ••• | ••• | ••• |
| Company 5 | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →Report Scope & Analysis
According to Cognitive Market Research, the global Mumps Virus Testing market size was estimated at USD XX Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.
- The United Kingdom Mumps Virus Testing market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 11.3% during the forecast period. In the UK, Mumps Virus Testing sales witness an upswing due to the nation's emphasis on public health initiatives and the resurgence of mumps cases in certain areas.
- The France Mumps Virus Testing market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD XX million in 2024.
- According to Cognitive Market Research, the German Mumps Virus Testing market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period. In Germany, Mumps Virus Testing surged due to the emphasis on public health initiatives and the resurgence of mumps cases in certain areas.
- The Italy Mumps Virus Testing market is projected to witness growth at a CAGR of 9.9% during the forecast period, with a market size of USD XX million in 2024.
- The Russia Mumps Virus Testing market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD XX million in 2024.
- The Spain Mumps Virus Testing market is projected to witness growth at a CAGR of 9.6% during the forecast period with a market size of USD XX million in 2024
- The Luxembourg Mumps Virus Testing market is projected to witness growth at a CAGR of 10.6% during the forecast period, with a market size of USD XX million in 2024.
- The Portugal Mumps Virus Testing market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD XX million in 2024.
- The Greece Mumps Virus Testing market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD XX million in 2024.
- Rest of Europe's Mumps Virus Testing market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD XX million in 2024.
The Mumps Virus Testing Market in Europe is witnessing consistent growth, driven by the region's emphasis on public health initiatives and the resurgence of mumps cases in certain areas. Europe's well-established healthcare systems and the proactive approach of governments in monitoring and controlling infectious diseases have spurred the adoption of reliable diagnostic tests. Among the testing types, RT-PCR has gained prominence due to its superior accuracy and rapid results. This method is particularly valued in Europe for its ability to provide early and precise detection of the mumps virus, aiding in effective outbreak management and minimizing the spread within communities.
Analyst Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Europe Mumps Virus Testing Market Analysis is witnessing significant growth in the near future.
In 2023, the RT-PCR segment accounted for a notable share of the Europe Mumps Virus Testing Market Analysis.
Frequently Asked Questions
★ Reviews
Rate this report
Europe Mumps Virus Testing Market Analysis — Table of Contents
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
| Testing type | RT-PCR, Other |
|---|---|
| End user | Hospitals, Clinics, Diagnostic Laboratories, Research Institutes, Other End Users |
| List of Competitors | Cortez Diagnostics, ZeptoMetrix, McKesson Medical-Surgical, NovaTec Immundiagnostica, Arlington Scientific |
Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))
- 1.1 Top Competitors Analysis
- 1.1.1 Top Players Ranking 2024
- 1.1.2 New Product Launch Analysis
- 1.2 Company Profile (Data Subject to Availability) Sample Format
- 1.2.1 Cortez Diagnostics
- 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.1.2 Business Overview
- 1.2.1.3 R&D Investment (Subject to data availability)
- 1.2.1.4 Financials (Subject to data availability)
- 1.2.1.5 Product Types Specification
- 1.2.1.6 Business Strategy
- 1.2.1.7 Recent Developments
- 1.2.1.8 Management Change
- 1.2.1.9 S.W.O.T Analysis
- 1.2.2 ZeptoMetrix
- 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.2.2 Business Overview
- 1.2.2.3 R&D Investment (Subject to data availability)
- 1.2.2.4 Financials (Subject to data availability)
- 1.2.2.5 Product Types Specification
- 1.2.2.6 Business Strategy
- 1.2.2.7 Recent Developments
- 1.2.2.8 Management Change
- 1.2.2.9 S.W.O.T Analysis
- 1.2.3 McKesson Medical-Surgical
- 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.3.2 Business Overview
- 1.2.3.3 R&D Investment (Subject to data availability)
- 1.2.3.4 Financials (Subject to data availability)
- 1.2.3.5 Product Types Specification
- 1.2.3.6 Business Strategy
- 1.2.3.7 Recent Developments
- 1.2.3.8 Management Change
- 1.2.3.9 S.W.O.T Analysis
- 1.2.4 NovaTec Immundiagnostica
- 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.4.2 Business Overview
- 1.2.4.3 R&D Investment (Subject to data availability)
- 1.2.4.4 Financials (Subject to data availability)
- 1.2.4.5 Product Types Specification
- 1.2.4.6 Business Strategy
- 1.2.4.7 Recent Developments
- 1.2.4.8 Management Change
- 1.2.4.9 S.W.O.T Analysis
- 1.2.5 Arlington Scientific
- 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.5.2 Business Overview
- 1.2.5.3 R&D Investment (Subject to data availability)
- 1.2.5.4 Financials (Subject to data availability)
- 1.2.5.5 Product Types Specification
- 1.2.5.6 Business Strategy
- 1.2.5.7 Recent Developments
- 1.2.5.8 Management Change
- 1.2.5.9 S.W.O.T Analysis
- 1.2.1 Cortez Diagnostics
- 1.1 Top Competitors Analysis
Chapter 2. Global Mumps Virus Testing Market Analysis
- 2.1 Global Mumps Virus Testing Market Analysis
- 2.2 Global Mumps Virus Testing Market Analysis by Testing type
- 2.3 Global Mumps Virus Testing Market Analysis by End user
Chapter 3. Europe Mumps Virus Testing Market Analysis
- 3.1 Europe Mumps Virus Testing Market Analysis
- 3.2 Europe Mumps Virus Testing Market Analysis by Country
- 3.3 Europe Mumps Virus Testing Market Analysis by Testing type
- 3.4 Europe Mumps Virus Testing Market Analysis by End user
- 3.5 Europe Mumps Virus Testing Market Analysis by Key Players
Chapter 4. United Kingdom Mumps Virus Testing Market Analysis
- 4.1 United Kingdom Mumps Virus Testing Market Analysis
- 4.2 United Kingdom Mumps Virus Testing Market Analysis by Testing type
- 4.3 United Kingdom Mumps Virus Testing Market Analysis by End user
- 4.4 United Kingdom Mumps Virus Testing Market Analysis by Key Players
Chapter 5. France Mumps Virus Testing Market Analysis
- 5.1 France Mumps Virus Testing Market Analysis
- 5.2 France Mumps Virus Testing Market Analysis by Testing type
- 5.3 France Mumps Virus Testing Market Analysis by End user
- 5.4 France Mumps Virus Testing Market Analysis by Key Players
Chapter 6. Germany Mumps Virus Testing Market Analysis
- 6.1 Germany Mumps Virus Testing Market Analysis
- 6.2 Germany Mumps Virus Testing Market Analysis by Testing type
- 6.3 Germany Mumps Virus Testing Market Analysis by End user
- 6.4 Germany Mumps Virus Testing Market Analysis by Key Players
Chapter 7. Italy Mumps Virus Testing Market Analysis
- 7.1 Italy Mumps Virus Testing Market Analysis
- 7.2 Italy Mumps Virus Testing Market Analysis by Testing type
- 7.3 Italy Mumps Virus Testing Market Analysis by End user
- 7.4 Italy Mumps Virus Testing Market Analysis by Key Players
Chapter 8. Russia Mumps Virus Testing Market Analysis
- 8.1 Russia Mumps Virus Testing Market Analysis
- 8.2 Russia Mumps Virus Testing Market Analysis by Testing type
- 8.3 Russia Mumps Virus Testing Market Analysis by End user
- 8.4 Russia Mumps Virus Testing Market Analysis by Key Players
Chapter 9. Spain Mumps Virus Testing Market Analysis
- 9.1 Spain Mumps Virus Testing Market Analysis
- 9.2 Spain Mumps Virus Testing Market Analysis by Testing type
- 9.3 Spain Mumps Virus Testing Market Analysis by End user
- 9.4 Spain Mumps Virus Testing Market Analysis by Key Players
Chapter 10. Sweden Mumps Virus Testing Market Analysis
- 10.1 Sweden Mumps Virus Testing Market Analysis
- 10.2 Sweden Mumps Virus Testing Market Analysis by Testing type
- 10.3 Sweden Mumps Virus Testing Market Analysis by End user
- 10.4 Sweden Mumps Virus Testing Market Analysis by Key Players
Chapter 11. Denmark Mumps Virus Testing Market Analysis
- 11.1 Denmark Mumps Virus Testing Market Analysis
- 11.2 Denmark Mumps Virus Testing Market Analysis by Testing type
- 11.3 Denmark Mumps Virus Testing Market Analysis by End user
- 11.4 Denmark Mumps Virus Testing Market Analysis by Key Players
Chapter 12. Switzerland Mumps Virus Testing Market Analysis
- 12.1 Switzerland Mumps Virus Testing Market Analysis
- 12.2 Switzerland Mumps Virus Testing Market Analysis by Testing type
- 12.3 Switzerland Mumps Virus Testing Market Analysis by End user
- 12.4 Switzerland Mumps Virus Testing Market Analysis by Key Players
Chapter 13. Luxembourg Mumps Virus Testing Market Analysis
- 13.1 Luxembourg Mumps Virus Testing Market Analysis
- 13.2 Luxembourg Mumps Virus Testing Market Analysis by Testing type
- 13.3 Luxembourg Mumps Virus Testing Market Analysis by End user
- 13.4 Luxembourg Mumps Virus Testing Market Analysis by Key Players
Chapter 14. Rest of Europe Mumps Virus Testing Market Analysis
- 14.1 Rest of Europe Mumps Virus Testing Market Analysis
- 14.2 Rest of Europe Mumps Virus Testing Market Analysis by Testing type
- 14.3 Rest of Europe Mumps Virus Testing Market Analysis by End user
- 14.4 Rest of Europe Mumps Virus Testing Market Analysis by Key Players
Chapter 15. Testing type Analysis
- 15.1 RT-PCR
- 15.2 Other
Chapter 16. End user Analysis
- 16.1 Hospitals
- 16.2 Clinics
- 16.3 Diagnostic Laboratories
- 16.4 Research Institutes
- 16.5 Other End Users
Chapter 17. Qualitative Analysis (Subject to Data Availability)
- 17.1 Market Drivers
- 17.2 Market Restraints
- 17.3 Market Trends
- 17.4 Market Opportunity
- 17.5 Technological Road Map (Subject to Data Availability)
- 17.6 Product Life Cycle (Subject to Data Availability)
- 17.7 Customer and Buyer Behavior Analysis
- 17.7.1 Digital Engagement, Customer Experience & Relationship Analysis
- 17.7.2 Customer Buying Behavior & Purchase Decision Analysis
- 17.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
- 17.7.4 Pricing, Affordability & Value Perception Analysis
- 17.7.5 Customer Segmentation & Demand Pattern Analysis
- 17.8 Industrial Chain Analysis (Subject to Data Availability)
- 17.8.1 Industry Chain Analysis
- 17.8.2 Manufacturing Cost Analysis
- 17.8.3 Supply Side Analysis
- 17.8.3.1 Raw Material Analysis
- 17.8.3.2 Raw Material Procurement Analysis
- 17.8.3.3 Raw Material Price Trend Analysis
- 17.9 PESTEL Analysis
- 17.9.1 Environmental Factors
- 17.9.2 Legal Factors
- 17.9.3 Technological Factors
- 17.9.4 Economic Factors
- 17.9.5 Political Factors
- 17.9.6 Social Factors
- 17.10 Porter’s Five Forces Analysis
- 17.10.1 Degree of Competition
- 17.10.2 Threat of Substitutes
- 17.10.3 Threat of New Entrants
- 17.10.4 Bargaining Power of Buyers
- 17.10.5 Bargaining Power of Suppliers
- 17.11 Patent Analysis (Subject to Data Availability)
- 17.12 ESG Analysis
- 17.13 Geopolitical Outlook
- 17.13.1 Global Power Realignment & Strategic Alliances
- 17.13.2 Geopolitical Risk Landscape & Conflict Hotspots
- 17.13.3 International Trade Relations & Market Access Environment
- 17.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
- 17.13.5 Supply Chain Resilience, Localization & Resource Nationalism
- 17.13.6 Technology Sovereignty & Digital Geopolitics
- 17.13.7 Strategic Implications for Investment, Growth & Market Entry
- 17.14 AI & Market Transformation
- 17.14.1 Competitive Landscape Disruption & Strategic Shifts
- 17.14.2 AI-Driven Transformation of Industry Value Chain
- 17.14.3 Evolution of Business Models & Revenue Streams
- 17.14.4 AI-Driven Product, Service & Innovation Transformation
- 17.14.5 Customer Behavior, AI Adoption & Future Market Evolution
Chapter 18. Research Findings
- 18.1 Key Takeaways
- 18.2 Analyst Point of View
- 18.3 Assumptions and Acronyms
Chapter 19. Research Methodology and Sources
- 19.1 Primary Data Collection
- 19.1.1 Steps for Primary Data Collection
- 19.1.1.1 Identification of KOL
- 19.1.2 Backward Integration
- 19.1.3 Forward Integration
- 19.1.4 How Primary Research Help Us
- 19.1.5 Modes of Primary Research
- 19.1.1 Steps for Primary Data Collection
- 19.2 Secondary Research
- 19.2.1 How Secondary Research Help Us
- 19.2.2 Sources of Secondary Research
- 19.3 Data Validation
- 19.3.1 Data Triangulation
- 19.4 Data Representation
- 19.1 Primary Data Collection
Athenaeum AI Dashboard
Our Proprietary Methodology
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Europe Mumps Virus Testing Market Analysis Market analysis.
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
Data Assurance Metrics
Analytical Coverage
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Sources from the Medical Devices and Consumables Industry
The Three Pillars of End-to-End Market Research Services
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Europe Mumps Virus Testing Market Analysis market.
Market Survey
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the europe mumps virus testing market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
- Buyer intent & sentiment analysis
- Purchase cycle mapping
- Price sensitivity research
- Channel preference profiling
- Competitive perception study
Customized Market Data & Reports
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
- Ready syndicate report
- Custom data scope & segmentation
- Excel quantitative models
- Board-ready PPT with key findings
- Secure cloud portal access
Strategic Consultation
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
- Dedicated analyst assigned to you
- Live walkthrough of findings
- Strategic Q&A sessions
- Go-to-market recommendations
- NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
